Abstract. A general procedure, relying heavily on mass spectrometry, has been developed for assigning structures to polypeptides. In the current version, amino acids are identified by HRFkBMS, GC/MS, and GC on chiral columns, and quantitated by CC. FAB mass spectrometry assigns the peptide's molecular weight and amino acid sequence, supported sometimes by selective hydrolysis to oligopeptides. The procedure has been applied to several pore-forming peptaibophol antibiotics, as well as to the didennins, cyclic depsipeptides isolated from a marine tunicate. The didemnins are active antitumor agents and show promise in the treatment of viral infections, including Rift Valley fever.
INTRODUCTION
Peptides certainly rank among the most biologically active natural products, providing man with his most potent toxins as well as with powerful hormones and useful antibiotics. Their chemistry and biology provide the subject matter of regular conferences in the United States (Ref. 1) and elsewhere (Ref. 2) . Our own active interest in peptides commenced with an attempt to employ mass spectrometry to the fullest extent in assigning structures to peptide antibiotics, but more recently has turned to a study of some particularly potent peptides derived from marine sources. This presentation will describe both efforts, but first the mass spectrometric study.
STUDY OF PEPTAIBOPHOL ANTIBIOTICS BY MASS SPECTROMETRY
With their assemblages of small units which can be cleaved selectively by chemical means between the carbonyl and amino groups, peptides have long provided tempting targets for study by mass spectrometry, since one needs only to deduce from their mass spectra the order in which the amino acids are linked. A number of chemical procedures have been applied to the problem of inducing preferential cleavage of this type at or near the amide bonds, including lithium aluminum hydride reduction to a CH2N grouping (Ref. 3) and N-methylation to convert secondary amides to tertiary amides (Ref. 4 ). In our own mass spectrometric studies of peptides we sought to minimize the number of chemical steps involved and required that the structures of the compounds should not be previously known. In addition, we preferred to work with peptides which for one reason or another might not be amenable to the elegant and Abbreviations used: Mass spectrometry, MS; high resolution, BR; field desorption, FD; electron impact or electron ionization, El; field ionization, Fl; fast atom bombardment, FAB; chemical ionization, CI; gas chromatography, GC; high performance liquid chromatography, HPLC; and the residues for a-aminoisobutyric acid, Aib; 4-hydroxyproline, Hyp; isovaline, c-amino-a-methylbutyric acid, Iva; proline, Pro; phenylalaninol, Phol; phenylalanine, Phe; glycine, Gly; leucine, Leu; glutanic acid, Glu; glutamine, Gln; glutamine or glutamic acid, Glx; ornithine, Orn; threonine, Thr; N-methylleucine, MeLeu; statine, y-amino--hydroxyisocaprylic acid, Sta; N,O-dimethyltyrosine, Me2Tyr; u-(u-hydroxyisovaleryl)propionic acid, Hip; acetyl, Ac; alanine, Ala; valine, Val; tryptophan, Trp. Antiamoebins, emerimicins, alamethicins--first general procedure The first peptide chosen for study was the antibiotic antiamoebin (Ref. 5 ) and the procedure ultimately developed in our laboratory for dealing with antiamoebin and other peptides is outlined in Table 1 
One of the more unusual techniques employed in General Procedure I is HRFDMS, used extensively throughout but most impressively in assigning the molecular formulas. Antiamoebin I In studying the sequence, the El mass spectrum was investigated as far as ions could be observed. In contrast to many other peptides, antiamoebin showed rather clean CO-N fragmentation, allowing the partial sequence shown in Scheme 1 to be assigned, which was confirmed by HREIMS. Additional information was obtained from oligopeptides, with their spectra obtained by HRFDMS and their derivatives' by GC/HREIMS and GC/FIMS. In addition to derivatized oligopeptides obtained from the non-polar N-terminus (including Phe-Aib), oligopeptides identified from the polar C-terminus included Hyp+GlnIva, G1u+Iva, Hyp--Aib-Pro and Pro--Phol. Overlapping these with the partial formula of Scheme 1 gave 1 as the structure of antiamoebin I. Ac
The structure assignment rested nearly entirely on mass spectrometric data, with only two simple reactions being carried out on antiamoebin--total hydrolysis to the constituent amino acids and partial hydrolysis to a mixture of oligopeptides--plus derivatizations. It may be noted that to this point no products had been isolated.
In addition, a highly selective cleavage was effected by treatment of antiamoebin I with trifluoroacetic acid at room temperature (Scheme 2), which gave only three major products, each derived from selective cleavage between an Aib unit and the adjacent Hyp or Pro unit (Ref. 6 ). This appears to have been the first such selective use of trifluoroacetic acid. It is of some interest that the selectivity in the trifluoroacetolysis is mimicked by selectivity in the mass spectrometer, where preferential mass spectrometric cleavage between Aib and Hyp or Pro is also observed. Indeed, the last fragmentation seen in the El mass spectrum of antiamoebin I (Scheme 1) is between Aib-9 and Pro-lO to give rn/z 884.
CF COOH Antiamoebin r.t., 24 hr Hyp--Gln±Iva + Hyp-*Aib + Pro+Phol
Precisely the same procedure outlined in Table 1 was employed in studying emerimicins III and IV (Ref. 9) and alamethicins I and II (Ref. 10) . Alamethicin differs considerably from antiamoebin and emerimicin in its amino acid composition and its sequencing was somewhat more difficult than that of the antiamoebins or emerimicins. The sequence developed did not establish which of the Glx units were present as Gin and which as Glu, nor did it distinguish between n-and y-linkages of the Gix units. To locate the single Glu residue, alamethicin was subjected to the trifluoroacetolysis technique developed previously for antiamoebin, giving as the major product the C-terminal "heptapeptide", 7.
This was derivatized to 8 and subjected to HREIMS, which demonstrated that Gin was attached to Phol and that Glu was attached to Gin, as shown in Scheme 3. To distinguish between n-and y-linkages, compound 7's methyl ester was dehydrated with diphenyl chiorophosphite and then reduced with sodium in liquid ammonia (Scheme 3) to convert carboxamide groups to primary amines and carbomethoxy groups to primary alcohols. Hydrolysis of 7 treated in this fashion identified Orn (derived from Gin) and 4-hydroxy-2-aminopentanoic acid (derived from Glu methyl ester). The structure of alamethicin I was assigned then as 5. The structure of alamethicin II (6) was deduced by noting the non-integral number of Ala residues and by observing homologous ions in the El mass spectrum which pointed to substitution of Ala by Aib at amino acid 6. Syntheses of structure 5 have been carried out (Ref. 14, 15) and biological properties of the natural product appear to match closely those of the synthetic material.
Since alamethicin had previously been recognized as having the property of forming pores in artificial membranes, facilitating transport of sodium and potassium ions, this pore-forming property was assayed for the antiamoebins and emerimicins and they were found to be active facilitators of ion transport (Ref. 16, 17 
Scheme 3. 
NH3 NH2
The first stage of our investigation of peptide structures by mass spectrometry was then completed with the assignment of structures to six peptaibophol antibiotics and the develop-. ment of a methodology largely dependent on HRFDNS and GC/HREIMS.
Zervamicins--second general procedure Investigations of the structures of zervamicins I and II (acidic and neutral, respectively) and emerimicin II (neutral) began almost as early as those of emerimicins III and IV, but these larger, more polar antibiotics proved considerably more difficult. Each contains one mole of tryptophan, a relatively fragile amino acid both hydrolytically and mass spectrometrically. Consequently, a number of the techniques developed for the other peptaibophols were unsuccessful with the zervamicins.
We have recently developed HPLC conditions for successfully separating complex mixtures of peptaibophol antibiotics, shown for zervamicin I and II in Fig. 2 . The major component of zervamicin I is zervamicin IC, the major components of zervamicin II are zervamicins IIB and IIA, but there are numerous minor components, some of them separated only by recycling. In addition, emerimicin II was shown to consist of a mixture of components identical to those of zervamicin II, and the name emerimicin II has now been abandoned in favor of zervamicin II. on the antibiotics and ElMS gave only a few fragment ions, generally of insufficient intensity for high resolution measurements.
Introduction of fast atom bombardment mass spectrometry (Ref. 18, 19) has altered our general procedure to that of Table 2 , where it can be seen that one FAB measurement has essentially replaced two FD and one El measurements. Remaining points of uncertainty involved the locations of Hyp, Leu and Ile. These were partially resolved by an HRFABMS measurement of the rn/z 1067 peak (1067.6088), which demonstrated that Leu and Ile (but not Hyp) remain on the N-terminal side of this cleavage and both Hyp units on the C-terminal side. No fragment ions were detected resulting from cleavage between amino acids 10, 11 and 12, which must have been Hyp, Gln and Aib. In deciding the relative positions of these units (as well as placing Hyp and Pro at amino acids 13 and 15, respectively), a tentative conclusion was reached based on the selective cleavage between Aib and Hyp noted for other peptaibophols (Ref. 6). To confirm this tentative assignment, a careful study of the partial hydrolysis products was carried out on the closely related zervamicin IIB (see below). In this study the oligopeptides Hyp-Aib, ProPhol, and Hyp-Gln-Aib were identified by GC/MS, thus completing the assignment of the sequence of the amino acids in the C-terminal region and the overall assignment except for distinguishing between Leu and Ile at amino acids 2, 5 and 8. The major neutral components, zervamicins hIB and hA, were sequenced to the same point by noting the replacement of Glu (in IC) by Gln (in IIB and hA) and of an Iva (in IC) by Aib (in IIA), with appropriate mass shifts in their FAB mass spectra (Scheme 4). The general procedure set forth in Table 2 is presently being investigated for peptides of other classes and should be of use in studying the structures of peptides with blocked N-and/or C-termini, as well as those difficult to cleave by enzymatic means due to the presence of unusual amino acids. We turn now to a rather different facet of our interest in peptides, to the isolation, structure proof and biological properties of the didemnins, a group of highly potent cyclic depsipeptides isolated from a Caribbean tunicate (also called an ascidian or sea squirt). The tunicate was originally demonstrated on shipboard to produce compounds having potent antiviral activity and cytotoxicity, as described elsewhere (Ref. 22) . These compounds were subsequently isolated in the laboratory in Urbana and named didemnins after the tunicate, a Tndidemnum species of the family Didemnidae. Preliminary reports of the structural assignments of didemnins A-C as 9-11 (here expanded to include known stereochemistry) (Ref. 
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STUDY OF MARINE-DERIVED CYCLIC DEPSIPEPTIDES
L-Leu
Didemnin A Although dideninin A is considerably less biologically active than didemnin B, it was chosen for the initial structural study because of its greater abundance and lower molecular weight. Dideninin A, suspected of being a peptide from its -H NNR spectrum, which contains NH protons near 8 ppm, was originally studied by the FD-based general procedure ( Table 1) . The mixture of amino acids obtained from total acid hydrolysis was converted to the amino acids' N-trifluoroacetyl -butyl esters and these were analyzed by GC, GC/HREINS and GC/CIMS and identified, in order of increasing retention time (Fig. 4) , as derivatives of Thr, Leu, MeLeu, Sta, Pro, anhydrostatine (Sta-H20) and MeTyr. The gas chromatogram indicated an approximately equimolar mixture of the six amino acids. Assignments of the structures of all of the compounds were confirmed by coinjection with authentic samples (Ref. 25 ) and statine was assigned by coinjection as the R,S (or S,R), erfl, isomer. The FD mass spectrum of the total acid hydrolyzate (Fig. 5) showed peaks at rn/z 209, 175, 146, 132, 116 and 101 for the "molecular ions" (M, M + H or N -H20) of Me2Tyr, Sta, MeLeu, Leu, Pro and Thr, plus a large peak at rn/z 156.
The chirality of the amino acids was determined for Pro, Leu and Thr by resolution of their derivatives' racemic mixtures on a capillary column packed with a chiral substrate and comparison with the natural products' derivatives' retention times (Fig. 6) , while the MeLeu and Me2Tyr derivatives were not resolved, but were isolated by preparative CC and their rotations were compared with those of authentic samples. The stereochemistry at C-4 of statine was assigned as R by isolation of the anhydrostatine derivative (12) and comparison of its rotation with that obtained for the anhydrostatine derivative from 3S,4S-statine (Ref. 25) .
Identification of the amino acids in didemnin A did not identify all the structural units.
Addition of the unit weights for the six amino acids gave only 784 daltons, or the calculated precise mass 784.4891, while the molecular weight of dideinnin A was determined to be 942.5678
by both HREINS and HRFABMS. Thus, 156.0787 amu (C8H1203) remained. This piece of the molecule did not appear derivatized in the CC trace, but was observed in the FD mass spectrum of the mixture of amino acids as 156.0794 (C8H1203). Originally, the structure of the C8 unit was assigned as -O-CH(iso-C3H7)COCH(CH3)C0-by observation of its smaller sub-units in the -H and -3C NNR spectra of didemnin A. Subsequently, the lactone of the hydroxy acid was isolated by extracting the aqueous hydrolyzate (amino acid mixture) with ether, and the NMR spectrum indicated cyclization to a lactone, 13. . Relative (hence, absolute) stereochemistry at C-2 was derived from a reduction product obtained by reducing didemnin A with sodium borohydride (Scheme 6) to give a mixture of products in each of which the -keto grouping of Hip had been reduced to a secondary alcohol. Hydrolysis of the mixture of borohydride-reduced products gave, among other compounds, the dihydrolactone 14, whose relative stereochemistry was assigned on the basis of 1H-1H coupling constants. While five-membered rings are flexible and the coupling constants for cis-trans pairs, in general, variable, an extremely small coupling constant (J L 1 Hz) can only be observed when hydrogens are trans on the five-membered ring (Ref. 27) . The H-2, H-3 coupling constant observed for 14 argues for trans stereochemistry at those positions. On the other hand, J3 was 9.7 Hz. Molecular models show that this coupling constant only agrees with H-3 and H-4 being cis. Thus, the complete stereochemistry of the dihydrolactone must be as shown for 14, which indicates that of Hip must be as shown in 9, completing the stereochemical assignment of the structural units of didemnin A.
Completing the structural assignment of didemnin A required assigning the sequence of the six amino acids and the single keto acid present. The molecular formula of didemnin A is completed by the seven known structural units, allowing for no terminal hydroxyl group as in a linear peptide; thus, the peptide was deemed to be cyclic. From the lfi NNR spectrum MeLeu was assigned as having a free N-CE3 group (N-terminal amino acid) and statine as having a free hydroxyl group. Following the normal procedure for peptide structure assignment (Table 1) , we turned to the HREI mass spectrum of didemnin A. Here, a key peak was at rn/z 178 (C10H1003), which can only be due to a methoxycinnanic acid ion, assuring that Me2Tyr is bound in an ester linkage to the hydroxyl group of Thr (since the hydroxyl group of Sta is free).
Beginning with this observation, the sequences Pro-Me2Tyr, Leu-Pro-Me2Tyr, Hip-Leu-ProMe2Tyr, Sta-Hip-Leu-Pro and Thr-Sta-Hip-Leu-Pro-Me2Tyr were assigned from the HREIMS peaks at rn/z 288, 401, 557, 523, and 815, respectively (Scheme 7), thus assigning the complete structure of didemnin A. Biologically active peptides and their mass spectra 2419
The structure of didemnin A was assigned from these observations before the advent of FABMS (Ref. 22, 23) , but the FAB mass spectra have recently been studied and they confirm the sequence. The positive and negative ion FAB mass spectral fragmentations of dideinnin A (Scheme 8) are extremely revealing, both in that they could de novo have assigned the sequence of dideinnin A, and in the differences between the FAB fragmentations and the El f ragmentations in Scheme 7. It was noted above that positive and negative ion FAB spectra are often complementary and this is illustrated particularly well for dideninin A. Other major points of interest are cleavage at the nitrogen of Pro, a cleavage noted above to be significant in the assignment of structures to the peptaibophols, and an especially prominent elimination of the acyloxy group of Thr as Me2TyrOH and related fragments.
+ FABMS Fragmentations for Didemnin A (and B)
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The sequences derived from El or FAB mass spectra of didemnin A are based on spectra of cyclic depsipeptides, which have previously given some difficulty due to rearrangements. To confirm these assignments, didemnin A was converted to two linear peptides. The sodium borohydride reduction, which gave the dihydrolactone 14 after hydrolysis, yielded a number of primary products, as shown in Scheme 6. Among these, the "tetrapeptide" 15 was isolated in which Hip had been reduced and both of the lactone linkages had been cleaved by reduction. Thus, hydrolysis of 15 gave dihydrolactone 14 (cycloHipH2), Leu, Pro and Me2Tyrol. Since HipH2 must have been N-terminal and Me2Tyrol must have been C-terminal, only two structures are allowed. These are readily distinguished by the FAB fragmentation pattern of 15 (Scheme 9), which could, for that matter, have assigned the structure of the reduced tetrapeptide de novo even in the absence of knowledge of the N-terminal and C-terminal units. Significant low-mass peaks were also identified at rn/z 70, 86, 121 and 164, characteristic of Pro, Leu and Me2Tyrol (or Me2Tyr).
In addition to 15, the exceedingly significant reduced "heptapeptide" 16 was isolated, in which, as usual, Hip had been reduced, but only a single lactone cleaved, giving an N-terminal NeLeu and a C-terminal Me2Tyrol unit, as judged by hydrolysis of 16 and identification of the components by GC/MS. The amino acid sequence of 16, and thus of didemnin A, would have been totally derivable by interpretation of its FAB mass spectrum. The fragment peaks shown in Scheme 9 indicate ions are derived from both the C-terminal and N-terminal regions of the peptide. Even without the knowledge that MeLeu is N-terminal, since it is N-terminal in didemnin A, and Me2Tyrol is C-terminal, the high resolution data completely define the structure of !&• Didemnin B With the structure of didemnin A in hand, attention shifted to the structure of didemnin B, the more active component. Hydrolysis of didemnin B gave the same amino acids as didemnin A but with an extra mole of Pro, which was shown to be the L-isomer by chiral GC. The molecular formula of dideinnin B (C57H89N7015) was in accord with the presence of a C3H402 unit in addition to the extra Pro unit. This was assigned as a lactic acid unit, Lac, which was not isolated but was identified in the NNR spectrum of didemnin B by its CH3CHOH-group and in its l3 NMR spectrum by an additional carboxyl carbon. The mass spectra of didemnin B (Scheme 8) are sufficiently similar to those of dideinnin A to argue persuasively for a nearly identical structure. The methylamino group of MeLeu is acylated in didemnin B, as judged by the NMR spectrum, so the branching point must be MeLeu and, since both Pro units are acylated, structure 10 was assigned. In accord with the assignment, acetylation of didemnm B effects changes in the chemical shifts of the Lac unit but not the Pro unit.
Didemnin C The third component of the didemnins, didemnin C, was shown to contain the same amino acids as didemnin A and in the same ratios, but didemnin C has an additional C3H402 unit, which from the 3-H NMR spectrum must be attached to MeLeu. Again, as with dideinnin B, this was assigned as a Lac unit although it was not isolated. Experiments to determine the stereochemistry of the Lac unit have not been conclusive. As an antiviral drug, didernnin B is exceedingly potent against both DNA and RNA viruses (Fig. 8) . Here again, didemnin B is the most active; for example, among DNA viruses it reduces virus titers by about 2 logs for Herpes simplex virus, types 1 and 2, at 0.5 pM (Ref. 28, 30) . Invivo, didemnin B has been shown to protect mice with vaginal infections of Herpes simplex virus, type 2, by topical application (Table 4) . Among the RNA viruses, the didemnins are active against influenza virus, para-influenza virus, Coxsackievirus and an equine rhinovirus, again at very low concentrations (Ref. 28, 30) . Most recently, the didemnins have been demonstrated to have considerable activity against a number of quite potent RNA viruses including Venezuelan equine encephalomyelitis, yellow fever, sand fly fever, and, most impressively, Rift Valley fever virus and a Pichinde virus related to Lassa fever virus ( Fig. 9 ) (Ref. 32) . It is especially satisfying to report the last two results in a lecture in Africa, since Rift Valley fever and Lassa fever are East African and West African diseases, commonly fatal in man, and there are no effective treatments at the present tine. With Rift Valley fever virus, mice were protected by didemnin B at relatively low concentrations (Table 5 ) and preparations are underway for carrying Out tests of these drugs against primates.
Although DNA and RNA syntheses are also affected, the principal mode of action of the didemnins appears to be inhibition of protein synthesis, which is affected to a degree paralleling the in vitro activity with didemnin B being the most active of the group (Ref. [28] [29] [30] .
Although the clinical utility of the didemnins is at present unclear, preliminary results from antitunor testing should be available within the next year. As with most potent compounds, extensive chemical manipulation will probably be required to optimize the therapeutic index. Regardless of their ultimate utility, however, there is no doubt that the didemnins provide yet another example of highly potent biologically active peptides and of the utility of mass spectrometry in elucidating their structures. 
